A trial of ixazomib, lenalidomide and dexamethasone for people with myeloma (FITNEsS)

This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough. It is looking at changing the dose of ixazomib, lenalidomide and dexamethasone to see if these people are better able to cope with treatment. The trial is for people who can’t have a stem cell transplant.

It is also looking at whether taking ixazomib with lenalidomide after the initial treatment works better than lenalidomide on its own. This is to keep myeloma under control.

Cancer Research UK supports this trial.